Diagnostics, Volume 15, Issue 19
2025 October-1 - 135 articles
Cover Story: Aberrant DNA methylation contributes to cancer progression. Although global hypomethylation is common in many cancers, including OSCC, our study revealed increased 5-methylcytosine levels at the invasive front, inversely correlated with tumor differentiation. Treatment with the DNA methyltransferase inhibitor 5-Aza-dC enhanced epithelial differentiation-related gene expression while suppressing EMT-associated gene expression. Moreover, conditioned medium from cancer-associated fibroblasts enhanced methylation and promoted migration of OSCC cells. These findings suggest that localized DNA hypermethylation drives OSCC progression by modulating differentiation and EMT. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.